{"nct_id":"NCT03066258","title":"Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial","status":"COMPLETED","status_verified_date":"2023-05","start_date":"2017-03-29","start_date_type":"ACTUAL","primary_completion_date":"2019-11-24","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-17","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["RGNX"]}